New Alzheimer’s drug slows disease by a third
After a second drug has been shown to slow the progression of Alzheimer’s disease in less than a year, we may be entering a new era of treatments. We were now “on the cusp” of having drugs available, according to experts, which had previously appeared “impossible.” Donanemab, a drug manufactured by Eli Lilly, is said…